Legal News 20 February 2026 - 15 May 2026

Fortescue Shares Face Test After A$150 Million Court Loss

Fortescue Shares Face Test After A$150 Million Court Loss

Fortescue shares closed Friday at A$22.60, down 1.7% for the day but up 6.3% for the week, as traders weigh a Federal Court order to pay the Yindjibarndi Ngurra Aboriginal Corporation A$150 million for cultural loss. The S&P/ASX 200 fell 0.12% Friday, with major miners also dropping. Fortescue shipped 48.4 million tonnes of iron ore in Q3 and maintained full-year guidance.
May 17, 2026
GSK Wins Court Ruling in Pfizer-BioNTech Covid Vaccine Patent Fight

GSK Wins Court Ruling in Pfizer-BioNTech Covid Vaccine Patent Fight

A U.S. judge dismissed Acuitas Therapeutics’ attempt to clear Pfizer and BioNTech’s Comirnaty vaccine of GSK patent claims, citing lack of jurisdiction, Bloomberg Law reported Friday. The decision keeps the focus on GSK’s main Delaware lawsuit alleging Comirnaty infringes mRNA-vaccine patents. Pfizer has pledged to defend its position. The ruling does not address whether infringement occurred.
May 9, 2026
JPMorgan Chase Faces Fresh Legal Pressure as Employee Drug-Cost Suit Moves Ahead

JPMorgan Chase Faces Fresh Legal Pressure as Employee Drug-Cost Suit Moves Ahead

A federal judge in Manhattan allowed JPMorgan Chase employees to pursue key claims in a proposed class action alleging the bank mismanaged its health and prescription benefits plan, leading to inflated drug and premium costs. The suit claims the plan paid markups averaging 211% on 366 generic drugs through CVS Caremark. JPMorgan declined to comment. The judge dismissed some fiduciary-duty claims but let prohibited-transaction claims proceed.
March 10, 2026
Navan (NAVN) stock slips in premarket as lawsuit overhang bites after Thursday rally

Navan (NAVN) stock slips in premarket as lawsuit overhang bites after Thursday rally

Navan shares dropped 2.7% to $10.30 in premarket trading Friday, reversing part of a 14% surge from the prior session. The company will report fourth-quarter and full-year results after markets close on March 25. Investors are watching a securities class action filed Feb. 23 over Navan’s October IPO, with an April 24 lead-plaintiff deadline. Greenoaks Capital Partners disclosed a 6.9% stake in the company.
February 27, 2026
Oracle stock price today: ORCL ticks up after hours as April 6 lawsuit deadline nears

Oracle stock price today: ORCL ticks up after hours as April 6 lawsuit deadline nears

Oracle shares rose 0.3% to $156.54 in after-hours trading Thursday, with about 14.9 million shares changing hands. A shareholder lawsuit filed Feb. 3 in Delaware accuses Oracle and top executives of misleading investors about how quickly AI-related spending would drive growth. Investors face an April 6 deadline to seek lead-plaintiff status in the case. Oracle recently said it aims to raise up to $50 billion in 2026 through debt and share sales.
February 20, 2026